Endothelial cell activation involves the elevated expression of cell adhesion molecules, chemoattractants, chemokines, and cytokines. These expression profiles may be regulated by integrin-mediated cell signaling pathways. In the current study, an ␣ 2  1 integrin triple helical peptide ligand derived from type I collagen residues ␣1(I)496 -507 was examined for induction of human aortic endothelial cell (HAEC) activation. In addition, a "miniextracellular matrix" composed of a mixture of the ␣1(I)496 -507 ligand and a second, ␣-helical ligand incorporating the endothelial cell proliferating region of SPARC (secreted protein acidic and rich in cysteine) was studied for induction of HAEC activation. Following HAEC adhesion to ␣1(I)496 -507, mRNA expression of Eselectin-1, vascular and intercellular cell adhesion molecules-1, and monocytic chemoattractant protein-1 was stimulated, whereas that of endothelin-1 was inhibited. Enzyme-linked immunosorbent assay analysis demonstrated that E-selectin-1 and monocytic chemoattractant protein-1 expression was also stimulated, whereas endothelin-1 protein expression diminished. Engagement of the ␣ 2  1 integrin initiated a HAEC response similar to that of tumor necrosis factor-␣-induced HAECs but was not sufficient to induce an inflammatory response. Addition of the SPARC 119 -122 region had only a slight effect on HAEC activation. Other cell-extracellular matrix interactions appear to be required to elicit an inflammatory response. The ␣ 2  1 integrin specific triple helical peptide ligand described herein represents a more general in vitro model system by which gene expression and protein production profiles induced by binding to a single cellular receptor type can be quantified.Blood vessels are lined with a contiguous endothelial cell layer. The endothelium lies just inside the medial cell layer of vascular smooth muscle cells, which, in turn, is surrounded by a layer of connective tissue. The location of the endothelial cell lining is such that it provides the interface between the flowing blood and the medial layer of the vessel.The endothelium, under normal physiological conditions, does not bind elements in the flowing blood but instead associates with smooth muscle cells and the extracellular matrix (ECM).1 These normal cell-cell and cell-matrix interactions are maintained, in part, by integrins on the endothelial cell surface (for review, see Ref. 1). Many integrins are involved in cellmatrix interactions; for example, five integrins